Published on 06.01.17 in Vol 3, No 1 (2017): Jan-Jun
Works citing "Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App"
According to Crossref, the following articles are citing this article (DOI 10.2196/cancer.6750):
(note that this is only a small subset of citations)
-
Lippi G, Mattiuzzi C, Plebani M. PSA-based, prostate cancer risk on-line calculators: no such thing as a crystal ball?. Diagnosis 2018;5(4):253
CrossRef -
Jamnadass E, Rai BP, Veneziano D, Tokas T, Rivas JG, Cacciamani G, Somani B. Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group. World Journal of Urology 2020;38(10):2411
CrossRef -
Tikka T, Paleri V, MacKenzie K. External validation of a cancer risk prediction model for suspected head and neck cancer referrals. Clinical Otolaryngology 2018;43(2):714
CrossRef -
Osses D, Roobol M, Schoots I. Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis. International Journal of Molecular Sciences 2019;20(7):1637
CrossRef -
Tapiero S, Yoon R, Jefferson F, Sung J, Limfueco L, Cottone C, Lu S, Patel RM, Landman J, Clayman RV. Smartphone technology and its applications in urology: a review of the literature. World Journal of Urology 2020;38(10):2393
CrossRef -
McNally CJ, Ruddock MW, Moore T, McKenna DJ.
Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
. Cancer Management and Research 2020;Volume 12:5225
CrossRef -
Nakai Y, Miyake M, Anai S, Hori S, Tatsumi Y, Morizawa Y, Onisi S, Tanaka N, Fujimoto K. Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid. Lasers in Medical Science 2018;33(7):1557
CrossRef -
Castaneda P, Ellimoottil C. Current use of telehealth in urology: a review. World Journal of Urology 2020;38(10):2377
CrossRef -
Govorko MH, Fritschi L, White J, Reid A. Identifying Asbestos-Containing Materials in Homes: Design and Development of the ACM Check Mobile Phone App. JMIR Formative Research 2017;1(1):e7
CrossRef -
Remmers S, Roobol MJ. Personalized strategies in population screening for prostate cancer. International Journal of Cancer 2020;147(11):2977
CrossRef -
Salmani H, Ahmadi M, Shahrokhi N. The Impact of Mobile Health on Cancer Screening: A Systematic Review. Cancer Informatics 2020;19:117693512095419
CrossRef -
Lombardo R, Tema G, Cancrini F, Albanesi L, Mavilla L, Tariciotti P, Gentile BC, Aloisi P, Rizzo G, Tardioli S, Giulianelli R. The role of immune PSA complex (iXip) in the prediction of prostate cancer. Biomarkers 2021;26(1):26
CrossRef -
Chen IA, Chu C, Lin J, Tsai J, Yu C, Sridhar AN, Sooriakumaran P, Loureiro RCV, Chand M. Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study. Journal of Medical Internet Research 2020;22(12):e16322
CrossRef -
Tully KH, Bahlburg H, Berg S, Hanske J, von Landenberg N, Noldus J, Palisaar R, Roghmann F, Brock M. Changing the Prostate Cancer Detection Paradigm: Clinical Application of European Association of Urology Guideline–recommended Magnetic Resonance Imaging–based Risk Stratification in Men with Suspected Prostate Cancer. European Urology Focus 2021;7(5):1011
CrossRef -
De Nunzio C, Lombardo R, Baldassarri V, Cindolo L, Bertolo R, Minervini A, Sessa F, Muto G, Bove P, Vittori M, Bozzini G, Castellan P, Mugavero F, Falsaperla M, Schips L, Celia A, Bada M, Porreca A, Pastore A, Al Salhi Y, Giampaoli M, Novella G, Rizzetto R, Trabacchin N, Mantica G, Pini G, Remmers S, Antonelli A, Tubaro A. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation. European Journal of Surgical Oncology 2021;47(10):2640
CrossRef -
Chiu PK, Shen X, Wang G, Ho C, Leung C, Ng C, Choi K, Teoh JY. Enhancement of prostate cancer diagnosis by machine learning techniques: an algorithm development and validation study. Prostate Cancer and Prostatic Diseases 2022;25(4):672
CrossRef -
Loeb S, Black PC, Wyatt AW, Nyame YA, Shore N, Tilki D, Castro E, Cooperberg M, Giri V, Ribal MJ, Lughezzani G, Sánchez-Salas R, Moore CM, Rastinehad A, Kerkmeijer L, Ahmed HU, Akamatsu S, de la Taille A, Gleave M, Tanguay S. B2B: Prostate Cancer. Société Internationale d’Urologie Journal 2021;2(Supplement 1):S30
CrossRef -
Bandala-Jacques A, Castellanos Esquivel KD, Pérez-Hurtado F, Hernández-Silva C, Reynoso-Noverón N. Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review. JMIR Cancer 2021;7(3):e30430
CrossRef -
Díaz-Fernández F, Celma A, Salazar A, Moreno O, López C, Cuadras M, Regis L, Planas J, Morote J, Trilla E. Systematic review of methods used to improve the efficacy of magnetic resonance in early detection of clinically significant prostate cancer. Actas Urológicas Españolas (English Edition) 2023;47(3):127
CrossRef -
Berg S, Tully KH, von Landenberg N, Bahlburg H, Roghmann F, Müller G, Hanske J, Noldus J, Brock M. How Many Cores Should Be Sampled during Systematic Prostate Biopsy in Case of Negative Multiparametric Magnetic Resonance Imaging? Analysis of 274 Men with Clinical Suspicion of Prostate Cancer. Urologia Internationalis 2022;106(9):914
CrossRef -
Gebeyehu S, Twinomurinzi H. A Collaborative Consumption Digital Platform for Government Organizations using Design Science. Digital Government: Research and Practice 2022;3(1):1
CrossRef -
Murtha JA, Liu N, Birstler J, Hanlon BM, Venkatesh M, Hanrahan LP, Borza T, Kushner DM, Funk LM. Obesity and “obesity-related” cancers: are there body mass index cut-points?. International Journal of Obesity 2022;46(10):1770
CrossRef -
Stocks J, Choi Y, Ibrahim S, Huchko M. Iterative Development of a Mobile Phone App to Support Community Health Volunteers During Cervical Cancer Screening in Western Kenya: Qualitative Study. JMIR Formative Research 2022;6(2):e27501
CrossRef -
Pospelova IV, Bragin DS, Cherepanova IV, Serebryakova VN, Sokolov AA, Kaveshnikov VS. Development of Mobile Application for Assessment of Basic Echocardiographic Parameters in Apparently Healthy Population. Telemedicine and e-Health 2021;
CrossRef -
Díaz-Fernández F, Celma A, Salazar A, Moreno O, López C, Cuadras M, Regis L, Planas J, Morote J, Trilla E. Revisión sistemática de los métodos para incrementar la eficacia de la resonancia magnética en el diagnóstico precoz de cáncer de próstata clínicamente significativo. Actas Urológicas Españolas 2023;47(3):127
CrossRef -
Berg S, Tully KH, Hoffmann V, Bahlburg H, Roghmann F, Müller G, Noldus J, Reike M. Assessment of complications after transperineal and transrectal prostate biopsy using a risk-stratified pathway identifying patients at risk for post-biopsy infections. Scandinavian Journal of Urology 2023;57(1-6):41
CrossRef -
van Breugel SJ, Low I, Christie ML, Pokorny MR, Nagarajan R, Holtkamp HU, Srinivasa K, Amirapu S, Nieuwoudt MK, Simpson MC, Zargar‐Shoshtari K, Aguergaray C. Raman spectroscopy system for real‐time diagnosis of clinically significant prostate cancer tissue. Journal of Biophotonics 2023;16(5)
CrossRef -
Greenberg JW, Koller CR, Casado C, Triche BL, Krane LS. A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer. Therapeutic Advances in Urology 2022;14:175628722210963
CrossRef -
Handke AE, Albers P, Schimmöller L, Bonekamp D, Asbach P, Schlemmer H, Hadaschik BA, Radtke JP. Systematische oder gezielte Fusionsbiopsie der Prostata. Die Urologie 2023;62(5):464
CrossRef -
Dite GS, Spaeth E, Murphy NM, Allman R. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk. The Prostate 2023;83(10):962
CrossRef -
Bahlburg H, Tully K, Hoffmann V, Hanske J, von Landenberg N, Roghmann F, Palisaar R, Noldus J, Berg S, Brock M. Avoiding Prostate Biopsies in Patients at Low Risk for Prostate Cancer: A Prospective Evaluation of a PSA-Density-Based Safety Net. Urologia Internationalis 2023;107(5):454
CrossRef -
Bouarroudj K, Kitouni I, Lechekhab A, Leghelimi Z, Kara I. Quality evaluation of commercially available healthcare applications for prostate cancer management. Multimedia Tools and Applications 2023;82(20):31793
CrossRef -
Singh A, Randive S, Breggia A, Ahmad B, Christman R, Amal S. Enhancing Prostate Cancer Diagnosis with a Novel Artificial Intelligence-Based Web Application: Synergizing Deep Learning Models, Multimodal Data, and Insights from Usability Study with Pathologists. Cancers 2023;15(23):5659
CrossRef -
Lieslehto J, Tiihonen J, Lähteenvuo M, Leucht S, Correll CU, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Development and Validation of a Machine Learning–Based Model of Mortality Risk in First-Episode Psychosis. JAMA Network Open 2024;7(3):e240640
CrossRef
According to Crossref, the following books are citing this article (DOI 10.2196/cancer.6750):
-
. Evaluation of Novel Approaches to Software Engineering. 2020. Chapter 9:188
CrossRef -
Teles A, Barros F, Rodrigues I, Barbosa A, Silva F, Coutinho L, Teixeira S. IoT and ICT for Healthcare Applications. 2020. Chapter 4:33
CrossRef -
McGrowder DA, Miller FG, Brown JG, Wilson-Clarke C, Anderson-Jackson L. Diagnostic Applications of Health Intelligence and Surveillance Systems. 2021. chapter 7:144
CrossRef